BioPharma, Pharma Novavax and Gavi Settle Dispute Over Covid Vaccines Pact, Avoiding Arbitration By Frank Vinluan
BioPharma, Pharma AstraZeneca’s Icosavax M&A Deal Helps It Stand Out in Multivalent Vaccines Chase By Frank Vinluan
BioPharma, Pharma FDA Approves Updated Covid-19 Vaccines to Address Now Circulating Variants By Frank Vinluan
BioPharma, Pharma The Public Health Emergency Is Expiring, So What Is the Future of Covid-19 Vaccines? By Frank Vinluan
BioPharma, Pharma FDA’s Covid-19 Changes Set Stage for the Vaccines to Emulate Seasonal Flu Shots By Frank Vinluan
BioPharma, Pharma Merck Vaccines Pipeline Gets Boost Via Deal for Opko Candidate for Epstein-Barr By Frank Vinluan
BioPharma Pfizer, Moderna Covid-19 vaccines are now authorized for kids as young as 6 months By Frank Vinluan
BioPharma, Pharma Covid-19 vaccines & therapies helped push medicines spending to $407B in 2021 By Frank Vinluan
BioPharma, Pharma Aiming to make better mRNA vaccines, BioNTech strikes up alliance with Matinas By Frank Vinluan
BioPharma, Legal Alnylam sues Moderna & Pfizer, claiming Covid-19 vaccines infringe lipid patent By Frank Vinluan
MedCity Influencers mRNA vaccines a potentially life-saving therapeutic option for people with occupational cancer By Jonathan Sharp
BioPharma, Pharma FDA sets expectations for pediatric Covid-19 vaccines; decision could come mid-fall By Frank Vinluan
BioPharma, Pharma Meissa Vaccines’ leg up in the Covid-19 vaccines chase goes through the nose By Frank Vinluan
BioPharma, Pharma Sanofi forms new mRNA vaccines unit to take the technology beyond Covid-19 By Frank Vinluan
